Does GLP-1 Actually Work? What the Evidence Shows (October 2026)

01 · The core answer

Does GLP-1 actually work for weight loss?

Yes: licensed GLP-1-based medicines have large, well-published trials behind them. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

Those are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² The numbers also show the spread. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.²

02 · Is this for you?

Is it relevant to you, and what to do next

It is relevant if you are an adult with obesity or overweight and weight-related health concerns, and have not got far with diet and activity alone. Whether you are suitable is a prescriber decision, not something a web page can settle. Treatment is also a long-term commitment, so it helps to go in understanding the pace, the side effects and the cost.

The practical next step is a free online consultation. A GPhC-registered prescriber reviews your answers, and unsuitable orders are refunded automatically. If you want to see doses and current prices, the Mounjaro pen page sets them out. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). Our weight loss clinic page explains the wider service.

Related guide: Does glp 1 actually work for weight loss.

Related guide: Do weight loss injections actually work.

03 · How GLP-1 works

How GLP-1 medicines work

GLP-1 medicines copy a natural gut hormone, and the clinical effect is that most people feel fuller sooner and less hungry between meals. For Mounjaro, the mechanism is dual. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹

Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That is the key point: the medicine makes eating less easier, but it does not do the dieting for you.

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ For a plain-English walkthrough, see how Mounjaro actually works and what a GLP-1 actually does.

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

04 · Realistic pace

How quickly does it work?

Slowly and by design, so think in months, not days. Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.²

Trials measured results at 72 weeks — think in months, not days, and judge progress by trend, not individual weigh-ins.² Be wary of sellers making dramatic weight-loss claims within weeks. Those promises are a warning sign, not an evidence-based expectation.

Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures. In SURMOUNT-1, average weight loss built month by month, with the full averages measured at 72 weeks.² Slower early progress does not predict failure — the dose you respond to may still be ahead of you.²

The first weeks are not the same for everyone. The 2.5mg starting weeks are about adjustment, and experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose — both are normal. Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.²

05 · When it doesn't work

What if it does not seem to be working?

A slow start or a stall is not automatically failure, and your prescriber reviews your response on a set timeline. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.²

Plateaus are part of the picture too. Weight loss on Mounjaro is not linear — plateaus of a few weeks are normal and expected as the body adapts to a lower weight.² Within the licence, the responses are:

• review food intake honestly, because portions drift back up;
• protect protein and activity;
• check the basics, such as sleep and alcohol;
• discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.

A plateau is not a reason to double doses or add unlicensed products.² If you stop treatment altogether, the medicine does not leave the body at once. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹

06 · The downsides

What are the downsides of GLP-1 medicines?

The main downsides are early digestive side effects, a long-term commitment and the cost. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.²

Other honest downsides are practical:

• It is a prescription-only medicine, so a prescriber must decide it suits you.
• It works alongside a reduced-calorie diet and increased physical activity, so it does not remove the effort.
• Results vary, and some people respond less than the trial averages.
• You need a plan for after treatment, which is best made with your prescriber.

If you notice a new symptom, tell your prescriber. You can also report suspected side effects through the MHRA Yellow Card scheme.¹⁹ Our ongoing monthly reviews and side-effect support exist for exactly this reason.

07 · Beyond the scales

Does it do more than reduce weight?

In trials it did, though these are secondary outcomes rather than promises. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.²

These are trial-average secondary outcomes, not promises — but they are why prescribers talk about weight management as health management rather than appearance.²

08 · Boosters and supplements

Do "GLP-1 boosters" actually work?

"GLP-1 boosters" are supplements marketed as raising your own GLP-1 levels. They are available cheaply without assessment, with no clinical oversight, and their dosing is not standardised.

The same applies to the nickname "poor man's Ozempic", which is a marketing label usually attached to berberine. Be wary of sellers making dramatic weight-loss claims. Likewise, if anyone offers prescription injections without a consultation or prescription, walk away: that is a safety risk and may involve counterfeit pens.

The same caution applies to tablets and pills in general. Our guide to which weight loss pills actually work covers what is licensed and what is not.

09 · Mounjaro and semaglutide

What does semaglutide do, and is Mounjaro better?

Semaglutide is the single-action GLP-1 medicine in Wegovy, a licensed weight-management treatment, and in Ozempic, which is licensed for type 2 diabetes only and is not a UK weight-loss medicine. Wegovy comes as pens of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, stepping up after at least four weeks to the 2.4mg maintenance dose from week 17.¹⁸

Mounjaro differs because it activates both GIP and GLP-1 receptors, while semaglutide acts on GLP-1 alone.¹ Which suits you depends on your health profile, tolerance and prescriber advice, and your prescriber can advise. You can compare the Wegovy pen with Mounjaro on our site.

No single medicine is best for everyone. Both options are licensed, prescription-only and work alongside diet and activity.

10 · NHS or private

Can you get it on the NHS?

Yes, but access is phased. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶

Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁶ Our private route is official LillyDirect supply, genuine KwikPens, and free next-day tracked delivery. Same-day dispatch applies when you order by 3pm. All six doses are in stock.

Prices were checked 10 October 2026.

11 · After stopping

Do you gain weight back after stopping?

Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ The medicine itself clears the body over about four to five weeks after the last dose.¹

Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load. That conversation is far better held before the last pen than after it.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹